SMEs can apply for a share of £1.5million to support the evaluation of innovative medical devices, diagnostics and regulated digital health products.
The Office for Life Sciences (OLS) will work with Innovate UK, as part of UK Research and Innovation, to invest up to £1.5m in innovation projects. These will support developers of innovative medical devices, diagnostics and regulated digital technology to evaluate their product in a real world clinical setting.
All projects must be led by a UK-based SME. You can choose from 2 options:
- Planning and preparation for a study, for which total eligible project costs can be up to £50,000.
- A study to collect clinical performance and cost-effectiveness data, for which total project costs can be up to £250,000.
This competition provides support for micro, small or medium-sized enterprises (SMEs) to develop an evidence base for products that address NHS priorities.
This competition is aimed at SMEs that have developed and manufactured innovative medical devices, diagnostics or regulated digital healthcare products.
You must have gained a CE marking for your product and it must already be available for the NHS to purchase, but not marketed in the UK for more than five years. You must collect supporting clinical evidence of its performance, cost effectiveness and impact in the NHS. If Innovate UK decide to fund you, this evidence may help increase uptake of your product within the NHS.
The competition will support the development or design of plans for the collection of clinical data in a real-world setting, and also support the running of these studies.
Your proposal must:
- Describe the innovative or CE-marked device
- Show how your product is likely to have a significant impact, including increasing patient access to innovative technologies where appropriate
- Demonstrate how the product meets the priority needs, such as those reviewed in the NHS Long Term Plan
- Provide evidence that you are working with appropriate stakeholders including NICE, NHS, NIHR and AHSNs
- Outline how your study will allow NICE to evaluate the data you collect
Your project must:
- Focus on understanding evidence gaps and testing product performance to explain the operational impact of your product on the NHS
- Add data to the evidence base that can contribute to the health technology appraisal process, for instance by comparing the use of the new product with the current standard of care
- Involve potential breakthrough technologies
- Help improve methods and systems
Priority will be given to projects that are related to:
- Ageing well
- Digital transformation
- Learning disabilities and autism
- Mental health
- Personalised care
- Primary care
- Starting well
The total eligible project costs can be up to £50,000 for option 1 and up to £250,000 for option 2.
You can apply for funding of up to 50% of the total eligible project costs. Therefore, option 1 applications can claim a grant of up to £25,000. Option 2 applications can claim a grant of up to £125,000.
Projects must start by 12 December 2019 and must be completed by the end of December 2020.
Projects must have a total duration of between 3 and 12 months.
To lead a project or work alone you must:
- Be an SME based in England, Scotland, Wales or Northern Ireland
- Carry out your project within the NHS
- Have a product that is aligned with at least one of the NHS’s priority healthcare areas, such as those reviewed in the NHS Long Term Plan
- Have a product that is already available for the NHS to purchase, but that has been marketed in the UK for less than 5 years
- Outline relevant discussions you have had with the main stakeholders, such as the National Institute for Health Research (NIHR), National Institute for Health and Care Excellence and Academic Health Science Networks (AHSNs), to demonstrate the feasibility of your proposal
- Have gained a CE marking for your product
SMEs can work alone or in collaboration with other businesses or research organisations as non grant claiming partners or sub-contractors. Only the SME leading the project will be eligible to claim grant funding.
If your project does not fulfil these eligibility criteria, or you have not yet reached the point of delivering a detailed and feasible plan for the collection of relevant data in a clinical setting, you may wish to look to consider the NIHR i4i competition Challenge Awards 2019: real world implementation. The deadline for submission for stage 1 is 1pm on 12 June 2019.
Projects will not be eligible for funding under this competition if they involve:
- CE marked products that are not currently available to the NHS or have been marketed in the UK for more than 5 years
- Medical devices and diagnostics that do not focus on priority areas for the NHS
- Digital health products not regulated as a medical device
- Any cost for materials or capital usage as part of the application case
You must choose one of these.
Option 1: total project costs of up to £50,000
SMEs can apply for support to develop detailed and feasible plans for the collection of relevant data in a clinical setting. It is expected that such planning and evidence collection will involve discussion with appropriate stakeholders such as the NIHR, NICE and AHSNs.
Option 2: total project costs of up to £250,000
SMEs can apply for support to collect and analyse real-world data that helps evaluate the impact of a product. Plans for the collection and analysis of real world data must have been developed in discussion with appropriate stakeholders, such as NIHR, NICE and AHSNs.
You can use the funding to:
- Access innovation and advisory support services, including consultancy
- Support costs related to the collection and analysis of clinical data beyond that required for standard clinical care
Cresco Innovation works with companies to develop and implement innovation strategies. We help client companies identify opportunities to develop new products and services, and then create a package of support to ensure that the idea is turned into a commercial reality.
Our services include securing grants (as a team we have raised around £40million over three years), business planning, IP advice, access to finance and funders, project management and IP commercialisation support.
We regularly act as the interface with the funding bodies and help clients ensure that their projects are properly managed to ensure the best outcome for all.